{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:35:33Z","timestamp":1790386533400,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006466","name":"Cleveland State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006466","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["2R15AI 103889-02"],"award-info":[{"award-number":["2R15AI 103889-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bmc.2024.117751","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:09:49Z","timestamp":1715134189000},"page":"117751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synthesis and biological evaluation of orally active anti-Trypanosoma agents"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4044-4584","authenticated-orcid":false,"given":"Fatma M.","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0616-0462","authenticated-orcid":false,"given":"William R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0463-2510","authenticated-orcid":false,"given":"Xiaotong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Adbus Sayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabreena","family":"Ighneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenna","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8427-8891","authenticated-orcid":false,"given":"Cody M.","family":"Orahoske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-441X","authenticated-orcid":false,"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117751_b0005","unstructured":"WHO. Ending the neglect to attain the Sustainable Development Goals (A road map for neglected tropical disease 2021-2030) Overview. In: Word Health Organization. ; 2021."},{"key":"10.1016\/j.bmc.2024.117751_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/parasite\/2010171061","article-title":"Domestic animals as potential reservoir hosts of trypanosoma brucei gambiense in sleeping sickness foci in Cameroon","volume":"17","author":"Njiokou","year":"2010","journal-title":"Parasite"},{"key":"10.1016\/j.bmc.2024.117751_b0015","first-page":"90","article-title":"Trypanosome Infection in Cattle and African Sleeping Sickness","volume":"5","author":"Smith","year":"2007","journal-title":"Int J Global Health and Health Disparities"},{"key":"10.1016\/j.bmc.2024.117751_b0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/pathogens10080967","article-title":"Regulation of antigenic variation by trypanosoma brucei telomere proteins depends on their unique DNA binding activities","volume":"10","author":"Li","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.bmc.2024.117751_b0025","doi-asserted-by":"crossref","unstructured":"Garrison P, Khan U, Cipriano M, et al. Turnover of Variant Surface Glycoprotein in Trypanosoma brucei Is a Bimodal Process. David Sibley L, ed. mBio. 2021;12(4). doi:10.1128\/mBio.01725-21.","DOI":"10.1128\/mBio.01725-21"},{"key":"10.1016\/j.bmc.2024.117751_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0166-6851(97)00183-7","article-title":"Expression and function of surface proteins in Trypanosoma brucei","volume":"91","author":"Pays","year":"1998","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2024.117751_b0035","doi-asserted-by":"crossref","unstructured":"Krishna S, Kleine C, Stich A. African Trypanosomiasis. In: Hunter\u2019s Tropical Medicine and Emerging Infectious Diseases. Tenth Edit. Elsevier; 2020:755-761. doi:10.1016\/B978-0-323-55512-8.00102-2.","DOI":"10.1016\/B978-0-323-55512-8.00102-2"},{"key":"10.1016\/j.bmc.2024.117751_b0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-4017(00)00427-1","article-title":"Drug resistance in pathogenic african trypanosomes: what hopes for the future?","volume":"96","author":"Anene","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.bmc.2024.117751_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.bmc.2024.117751_b0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117751_b0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0924-8579(94)90012-4","article-title":"Drug used in the treatment of sleeping sickness (Human African Trypanosomiasis: HAT)","volume":"4","author":"W\u00e9ry","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2024.117751_b0060","doi-asserted-by":"crossref","unstructured":"Franco JR, Cecchi G, Priotto G, et al. Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018. Matovu E, ed. PLoS Negl Trop Dis. 2020;14(5):e0008261. doi:10.1371\/journal.pntd.0008261.","DOI":"10.1371\/journal.pntd.0008261"},{"key":"10.1016\/j.bmc.2024.117751_b0065","first-page":"35","article-title":"Anti-trypanosomatid drug discovery: progress and challenges","volume":"21","author":"De Rycker","year":"2023","journal-title":"Nat RevMicrobiol"},{"key":"10.1016\/j.bmc.2024.117751_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"Torreele","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.bmc.2024.117751_b0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40267-019-00672-2","article-title":"Fexinidazole in human African trypanosomiasis: a profile of its use","volume":"35","author":"Deeks","year":"2019","journal-title":"Drugs & Therapy Perspectives"},{"key":"10.1016\/j.bmc.2024.117751_b0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2024.117751_b0085","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1016\/j.bmcl.2012.07.023","article-title":"Identification of selective tubulin inhibitors as potential anti-trypanosomal agents","volume":"22","author":"Lama","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117751_b0090","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1124\/mol.64.6.1325","article-title":"Selective antimicrotubule activity of N1-phenyl-3, 5-dinitro-N4, N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites","volume":"64","author":"Werbovetz","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2024.117751_b0095","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/1389557023405648","article-title":"Tubulin as an antiprotozoal drug target","volume":"2","author":"Werbovetz","year":"2002","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2024.117751_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116740","article-title":"Synthesis and biological evaluation of imidamide analogs as selective anti-trypanosomal agents","volume":"61","author":"Bobba","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117751_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2017.04.009","article-title":"Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents","volume":"25","author":"Bobba","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117751_b0110","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bmc.2019.02.049","article-title":"Lead optimization of selective tubulin inhibitors as anti-trypanosomal agents","volume":"27","author":"Zhao","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117751_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13321-019-0330-2","article-title":"The nature of ligand efficiency","volume":"11","author":"Kenny","year":"2019","journal-title":"J Cheminform"},{"key":"10.1016\/j.bmc.2024.117751_b0120","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1021\/acsinfecdis.2c00331","article-title":"Identification of prazosin as a potential flagellum attachment zone 1(FAZ1) inhibitor for the treatment of human African trypanosomiasis","volume":"8","author":"Orahoske","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2024.117751_b0125","article-title":"Orally active and selective tubulin inhibitors as anti-trypanosome agents","volume":"11","author":"Nanavaty","year":"2016","journal-title":"PLoS One1"},{"key":"10.1016\/j.bmc.2024.117751_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi0506s15","article-title":"Comparative protein structure modeling using modeller","volume":"15","author":"Eswar","year":"2006","journal-title":"Curr Protoc Bioinformatics"},{"key":"10.1016\/j.bmc.2024.117751_b0135","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013818","article-title":"Inhibiting parasite proliferation using a rationally designed anti-tubulin agent","volume":"13","author":"Gaillard","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bmc.2024.117751_b0140","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.bmc.2024.117751_b0145","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2024.117751_b0150","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2024.117751_b0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2024.117751_b0160","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2024.117751_b0165","doi-asserted-by":"crossref","DOI":"10.1063\/5.0019056","article-title":"A fast and high-quality charge model for the next generation general AMBER force field","volume":"153","author":"He","year":"2020","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2024.117751_b0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX."},{"key":"10.1016\/j.bmc.2024.117751_b0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1103\/PhysRev.159.98","article-title":"\u201cExperiments\u201d on Classical Fluids. I. Thermodynamical Properties of Lennard-Jones Molecules","volume":"159","author":"Computer","year":"1967","journal-title":"Phys Rev"},{"key":"10.1016\/j.bmc.2024.117751_b0180","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N \u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2024.117751_b0185","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2024.117751_b0190","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2024.117751_b0195","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J Appl Phys"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:06:22Z","timestamp":1717423582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"alternative-id":["S0968089624001652"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117751","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of orally active anti-Trypanosoma agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117751"}}